| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,036 |
3,734 |
$405K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,290 |
1,863 |
$117K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,294 |
1,178 |
$106K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,246 |
1,912 |
$77K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,121 |
1,732 |
$64K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,029 |
952 |
$49K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,378 |
1,892 |
$36K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
593 |
543 |
$26K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
875 |
819 |
$20K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
188 |
170 |
$13K |
| 96160 |
|
911 |
784 |
$13K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,071 |
798 |
$13K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
87 |
80 |
$12K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
71 |
61 |
$5K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
88 |
62 |
$4K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
51 |
43 |
$4K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
116 |
115 |
$4K |
| 87634 |
|
70 |
61 |
$4K |
| 87503 |
|
179 |
161 |
$3K |
| 94760 |
|
605 |
517 |
$3K |
| 96127 |
|
141 |
125 |
$2K |
| 99384 |
|
17 |
14 |
$2K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
71 |
61 |
$2K |
| 81001 |
|
557 |
472 |
$2K |
| 86580 |
|
263 |
240 |
$1K |
| 92551 |
|
78 |
65 |
$1K |
| 99173 |
|
142 |
125 |
$1K |
| 81002 |
|
252 |
236 |
$645.90 |
| 93000 |
|
27 |
27 |
$552.60 |
| 93042 |
|
12 |
12 |
$48.69 |